Effects of pioglitazone on metabolic control and blood pressure: a randomised study in patients with type 2 diabetes mellitus

P. G. Gerber, P.; Lübben, G; Heusler, Sabine; Dodo, Ayako

doi:10.1185/030079903125002180

Public

Effects of pioglitazone on metabolic control and blood pressure: a randomised study in patients with type 2 diabetes mellitus

Published in Current Medical Research and Opinion • Jan 1, 2003

Authors:

P. P. G. Gerber

G Lübben

Sabine Heusler

Abstract

AIM: This Swiss multicentre study examined the efficacy and safety of oral pioglitazone in patients with type 2 diabetes. METHODS: Patients were randomised to pioglitazone at once-daily doses of 30 mg for 20 weeks (n = 76), 30 mg for 12 weeks followed by 45 mg for 8 weeks (n = 74), or 45 mg for 20 w...

Subject

Pioglitazone

Medicine

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!